American Cannabis Company, Inc.
AMMJ · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $432 | $256 | $281 | $600 |
| % Growth | 68.8% | -9% | -53.1% | – |
| Cost of Goods Sold | $735 | $150 | $161 | $351 |
| Gross Profit | -$303 | $106 | $120 | $249 |
| % Margin | -70.2% | 41.4% | 42.8% | 41.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $249 | $232 | $1,960 | $326 |
| SG&A Expenses | $254 | $234 | $1,946 | $378 |
| Sales & Mktg Exp. | $4 | $2 | -$15 | $52 |
| Other Operating Expenses | $0 | $0 | $1,353 | $0 |
| Operating Expenses | $254 | $234 | $3,299 | $378 |
| Operating Income | -$557 | -$129 | -$3,179 | -$129 |
| % Margin | -129% | -50.3% | -1,130.6% | -21.5% |
| Other Income/Exp. Net | -$79 | -$4 | $97 | -$28 |
| Pre-Tax Income | -$636 | -$133 | -$3,082 | -$157 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$636 | -$133 | -$3,082 | -$157 |
| % Margin | -147.3% | -51.8% | -1,096.1% | -26.2% |
| EPS | -0.003 | -0.001 | -0.018 | -0.002 |
| % Growth | -385.7% | 96.1% | -900% | – |
| EPS Diluted | -0.003 | -0.001 | -0.018 | -0.002 |
| Weighted Avg Shares Out | 185,801 | 178,602 | 171,403 | 85,728 |
| Weighted Avg Shares Out Dil | 185,801 | 178,602 | 171,403 | 85,728 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $83 | $7 | $21 | $29 |
| Depreciation & Amortization | $60 | $72 | $60 | $60 |
| EBITDA | -$494 | -$54 | -$3,001 | -$69 |
| % Margin | -114.3% | -20.9% | -1,067.4% | -11.5% |